- No comments found
Data is the new currency now more than ever with the rise of artificial intelligence.
Synthetic data has emerged as a new form of currency that is revolutionizing the way businesses and organizations train their algorithms and models.
The future will provide tremendous computer computational power. But what might be trailing behind is the availability of data that is essential in processing and training. The Future is, at least in part, synthetic data.
Synthetic data is data that is generated by computer algorithms rather than being collected from the real world. It is becoming increasingly valuable in artificial intelligence (AI) for several reasons.
First, synthetic data can be used to train machine learning models when real-world data is not available or is difficult to obtain. Second, synthetic data can be used to test and evaluate AI models, especially in situations where real-world data is too scarce or too costly to use. Third, synthetic data can be used to generate new data sets that can be used to train and test models, which can be used to improve the performance of the models and increase their generalizability. Finally, synthetic data can be used to create data sets with specific properties, such as data sets that are balanced or that contain certain features, to train models that can perform well on specific tasks.
Gartner estimates that by 2024, 60% of the data used for the development of AI and analytics projects will be synthetically generated.
In medicine, synthetic data is used in a variety of ways. One common use case is in the development and training of medical imaging algorithms. For example, synthetic CT or MRI images can be generated that mimic real-world scans, and can be used to train deep learning models to detect and diagnose diseases. This can be useful in situations where obtaining real-world medical images is difficult or impossible, such as rare diseases or conditions that are difficult to replicate in a laboratory setting.
Another use case for synthetic data in medicine is in drug discovery and development. For example, synthetic data can be used to model the interactions between drugs and proteins, and can be used to predict the potential side effects of a drug before it is tested in humans.
Synthetic data can also be used to test the robustness and generalization of AI models in medicine. Since the model is trained on synthetic data, the model can be tested on the real-world data to validate its performance.
Synthetic data has the potential to revolutionize many areas of computing, including machine learning, computer vision, and natural language processing. By creating realistic simulations of data, synthetic data can be used to train and test AI models in a controlled environment, reducing the need for expensive and time-consuming data collection efforts. Additionally, synthetic data can be used to protect sensitive information by allowing organizations to share data without revealing sensitive information. In the future, synthetic data is likely to become an increasingly important tool in the development and deployment of AI systems. It certainly should be on your digital radar.
John is the #1 global influencer in digital health and generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change in the health / tech marketplaces. He is also a member of the Google Health Advisory Board, pens HEALTH CRITICAL for Forbes--a top global blog on health & technology and THE DIGITAL SELF for Psychology Today—a leading blog focused on the digital transformation of humanity. He is also on the faculty of Exponential Medicine. John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of advertising,” a process where strategy and creativity work together for superior marketing. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on acute myocardial infarction, ventricular arrhythmias and sudden cardiac death.
Leave your comments
Post comment as a guest